SG11202012620SA - Amino-pyrimidonyl derivatives, a process for their preparation and pharmaceutical compositions containing them - Google Patents

Amino-pyrimidonyl derivatives, a process for their preparation and pharmaceutical compositions containing them

Info

Publication number
SG11202012620SA
SG11202012620SA SG11202012620SA SG11202012620SA SG11202012620SA SG 11202012620S A SG11202012620S A SG 11202012620SA SG 11202012620S A SG11202012620S A SG 11202012620SA SG 11202012620S A SG11202012620S A SG 11202012620SA SG 11202012620S A SG11202012620S A SG 11202012620SA
Authority
SG
Singapore
Prior art keywords
pyrimidonyl
derivatives
amino
preparation
pharmaceutical compositions
Prior art date
Application number
SG11202012620SA
Other languages
English (en)
Inventor
Csaba Wéber
András Kotschy
Attila Vasas
Árpád Kiss
Balázs Molnár
Alba Macias
Andrea Fiumana
Nicholas Davies
James Brooke Murray
Emilie Sellier
Didier Demarles
Lisa Ivanschitz
Olivier Geneste
Original Assignee
Servier Lab
Vernalis R&D Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Servier Lab, Vernalis R&D Ltd filed Critical Servier Lab
Publication of SG11202012620SA publication Critical patent/SG11202012620SA/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/17—Lymphocytes; B-cells; T-cells; Natural killer cells; Interferon-activated or cytokine-activated lymphocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hematology (AREA)
  • Zoology (AREA)
  • Virology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
SG11202012620SA 2018-07-05 2019-07-04 Amino-pyrimidonyl derivatives, a process for their preparation and pharmaceutical compositions containing them SG11202012620SA (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
FR1856218 2018-07-05
EP19305398 2019-03-28
EP19305667 2019-05-27
PCT/EP2019/068050 WO2020008013A1 (fr) 2018-07-05 2019-07-04 Dérivés d'amino-pyrimidonyle, procédé de préparation de ceux-ci et compositions pharmaceutiques les contenant

Publications (1)

Publication Number Publication Date
SG11202012620SA true SG11202012620SA (en) 2021-01-28

Family

ID=67220800

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11202012620SA SG11202012620SA (en) 2018-07-05 2019-07-04 Amino-pyrimidonyl derivatives, a process for their preparation and pharmaceutical compositions containing them

Country Status (15)

Country Link
US (1) US20210221785A1 (fr)
EP (1) EP3818054A1 (fr)
JP (1) JP2021529772A (fr)
KR (1) KR20210029231A (fr)
CN (1) CN112368276A (fr)
AU (1) AU2019297489A1 (fr)
BR (1) BR112020026434A2 (fr)
CA (1) CA3104357A1 (fr)
IL (1) IL279873A (fr)
MA (1) MA53088A (fr)
MX (1) MX2020014327A (fr)
SG (1) SG11202012620SA (fr)
TW (1) TWI709559B (fr)
UY (1) UY38291A (fr)
WO (1) WO2020008013A1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4288430A1 (fr) * 2021-02-02 2023-12-13 Liminal Biosciences Limited Antagonistes du gpr84 et leurs utilisations

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102002063B (zh) 2009-09-01 2015-07-29 江苏先声药物研究有限公司 一类羧酸与β氨基酸组成的二肽硼酸及其酯类化合物、制备方法及其用途
TWI698436B (zh) * 2014-12-30 2020-07-11 美商佛瑪治療公司 作為泛素特異性蛋白酶７抑制劑之吡咯并及吡唑并嘧啶
HUE048590T2 (hu) * 2016-06-10 2020-08-28 Servier Lab Új (hetero)aril-szubsztituált piperidinil-származékok, eljárás ezek elõállítására és ezeket tartalmazó gyógyszerkészítmények
FR3052452B1 (fr) * 2016-06-10 2018-06-22 Les Laboratoires Servier Nouveaux derives de piperidinyle, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
GB201612938D0 (en) * 2016-07-26 2016-09-07 Almac Discovery Ltd Pharmaceutical compounds
GB201617758D0 (en) * 2016-10-20 2016-12-07 Almac Discovery Limited Pharmaceutical compounds

Also Published As

Publication number Publication date
MA53088A (fr) 2021-05-12
EP3818054A1 (fr) 2021-05-12
TW202019909A (zh) 2020-06-01
JP2021529772A (ja) 2021-11-04
UY38291A (es) 2020-06-30
KR20210029231A (ko) 2021-03-15
BR112020026434A2 (pt) 2021-03-23
AU2019297489A1 (en) 2021-01-21
WO2020008013A1 (fr) 2020-01-09
IL279873A (en) 2021-03-01
TWI709559B (zh) 2020-11-11
CA3104357A1 (fr) 2020-01-09
US20210221785A1 (en) 2021-07-22
MX2020014327A (es) 2021-03-09
CN112368276A (zh) 2021-02-12

Similar Documents

Publication Publication Date Title
ZA201808286B (en) New (hetero)aryl-substituted-piperidinyl derivatives, a process for their preparation and pharmaceutical compositions containing them
ZA201804770B (en) New ammonium derivatives, a process for their preparation and pharmaceutical compositions containing them
IL263463B (en) New piperidinyl compounds, a process for their preparation and pharmaceutical preparations containing them
HRP20181806T1 (hr) Novi aminokiselinski derivati, postupak za njihovu pripravu te farmaceutski pripravci koji ih sadrže
HK1254656A1 (zh) 新的二環衍生物、其製備方法以及含有它們的藥物組合物
HK1254657A1 (zh) 新的羥基酯衍生物、其製備方法以及含有它們的藥物組合物
IL282218A (en) New aminopyrimidonyl compounds, a process for their preparation and pharmaceutical preparations containing them
IL279873A (en) History of amino-pyrimidonyl, process for their preparation and pharmaceutical preparations containing them